Boston Heart Diagnostics
Healthcare Services · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
200 Crossing Blvd, Framingham, Massachus...Phone Number
(508) 877-8711Revenue
$63.4 MillionIndustry
ZI Rank: 3
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
3
4
3
3
About Boston Heart Diagnostics
Founded in 1982, Boston Heart, a Eurofins Scientific company,provide laboratory services, including genetic testing, chromatography, gel electrophoresis, and color coded diagnostics to healthcare providers and their cardiovascular patients to reduce costs of disease treatments. The company is headquartered in Framingham, Massachusetts.Explore more
Boston Heart Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Boston Heart Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Boston Heart Diagnostics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Boston Heart Diagnostics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Boston Heart Diagnostics recently announced quarterly report
Check out if Boston Heart Diagnostics is spiking on competitors!
Check if Boston Heart Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Boston Heart Diagnostics launches new products
Congratulate Masked Content for being promoted to Masked Content at Boston Heart Diagnostics
Boston Heart Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Boston Heart Diagnostics as Masked Content
Find more new buyers
Compare Similar Companies to Boston Heart Diagnostics
Compare insights from companies similar to Boston Heart Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Boston Heart Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Boston Heart Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Boston Heart Diagnostics.
Boston Heart Diagnostics financials insights
Gather financial insights about Boston Heart Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series A
$286K
2010
Private Equity
$10M
Boston Heart Diagnostics Tech Stack
A closer look at the technologies used by Boston Heart Diagnostics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Project
A front-line source has indicated that the organization's largest upcoming initiative will focus on additional testing efforts.
Project
A front-line source has indicated that the organization's largest upcoming initiative will be related to new testing.
Project
Product Management, Quality Management
Boston Heart Diagnostics News & Media
Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States
Nightingale Health Plc Company release, inside information 28 June 2024 at 9:35 a.m. (EEST) Nightingale Health Plc’s US subsidiary Nightingale Health United States, Inc. (“Nightingale Health”) and Boston Heart Diagnostics Corporation (“Boston Heart”) have signed a service agreement to provide Nightingale’s blood test based Health Check to Boston Heart in the United States. The agreement includes a pilot of the potential for broader roll-out to Boston Heart’s customer base and a letter of intentBoston Heart Diagnostics Launches LipoMap™: One of the Most Comprehensive Assessments of Lipid Metabolism Available
FRAMINGHAM, Mass., Oct. 3, 2022 /PRNewswire/ -- Boston Heart Diagnostics is pleased to announce the availability of LipoMap™. This panel of 33 lipid, lipoprotein, and apolipoprotein tests is performed via high-resolution 600 MHz nuclear magnetic resonance (NMR) and is one of the most...Boston Heart Diagnostics Launches Polygenic Risk Scores Empowering the Next Generation of Clinical Genomics
FRAMINGHAM, Mass., Sept. 12, 2022 /PRNewswire/ -- Boston Heart Diagnostics is pleased to announce the availability of the Polygenic Risk Map™. These genetic tests leverage Polygenic Risk Scores (PRS) to provide physicians with a much more precise understanding of their patient's absolute...Boston Heart Diagnostics Launches LipidSeq™-- An NGS Test for Common Genetic Disorders of Lipid Metabolism
FRAMINGHAM, Mass. , Aug. 17, 2022 /PRNewswire/ -- Boston Heart Diagnostics, part of the Eurofins network of companies, announces the launch of LipidSeq™, a revolutionary genetic test for cardiovascular disease. This saliva-based NGS test identifies the most common genetic causes of lipid...
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Boston Heart Diagnostics
Sign Up For FreeTo access detailed company insights
Founded in 1982, Boston Heart, a Eurofins Scientific company,provide laboratory services, including genetic testing, chromatography, gel electrophoresis, and color coded diagnostics to healthcare providers and their cardiovascular patients to reduce costs of disease treatments. The company is headquartered in Framingham, Massachusetts.... Read More
